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Abstract
Background: Evidence suggests that truth telling and honest disclosure of cancer diagnosis could
lead to improved outcomes in cancer patients. To examine such findings in Iran, this trial aimed to
study the various dimensions of quality of life in patients with gastrointestinal cancer and to
compare these variables among those who knew their diagnosis and those who did not.
Methods: A consecutive sample of patients with gastrointestinal cancer being treated in Cancer
Institute in Tehran, Iran was prospectively evaluated. A psychologist interviewed patients using the
Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ-C30). Patients were categorized into two groups: those who knew
their diagnosis and those who did not. Independent sample t-test was used for group comparisons.
Results: In all 142 patients were interviewed. A significant proportion (52%) of patients did not
know their cancer diagnosis and 48% of patients were aware that they had cancer. They were quite
similar in most characteristics. The comparison of quality of life between two groups indicated that
those knew their diagnosis showed a significant lower degree of physical (P = 0.001), emotional (P
= 0.01) and social functioning (P < 0.001), whereas the global quality of life and other functional
scales including role functioning and cognitive functioning did not show significant result. There
were no statistically significant differences between symptoms scores between two groups, except
for fatigue suggesting a higher score in patients who knew their diagnosis (P = 0.01). The financial
difficulties were also significantly higher in patients who knew their cancer diagnosis (P = 0.005).
Performing analysis of variance while controlling for age, educational status, cancer site, and
knowledge of cancer diagnosis, the results showed that the knowledge of cancer diagnosis
independently still contributed to the significant differences observed between two groups.
Conclusion: Contrary to expectation the findings indicated that patients who did not know their
cancer diagnosis had a better physical, social and emotional quality of life. It seems that due to
cultural differences between countries cancer disclosure guidelines perhaps should be differing.
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Background
A diagnosis of cancer often imposes a crisis, with the per-
son having to confront the illness and its treatment, and
deal with issues concerning the meaning of life, death,
and an uncertain future [1]. Thus historically there was a
belief that a patient should not be told about his or her
cancer diagnosis, and the question 'should patients be
told they have cancer?' has been addressed for a long time
as one of the most studied aspects in the literature of can-
cer communication [2]. While many argue that it is
important to give patients this information so that they
can make important decisions in an informed manner,
others suggest that giving this sort of information can
destroy hope. Moreover, based on some broad cultural
differences among those who hold one of these views,
whether or not to tell the truth about diagnoses and prog-
noses in such situations has arguably come to symbolize
the importance of cross-cultural differences in medical
practice [3,4].
Cancer and its treatments often produce significant mor-
bidities that undermine quality of life in survivors [5].
Quality of life (QOL) assessment is now considered as an
important component of evaluation in chronic disease,
particularly in cancer clinical trials [6]. There are few stud-
ies that investigate quality of life in cancer patients regard-
ing knowledge of cancer diagnosis. According to a study
from India, psychiatric morbidity is significantly lower in
patients who are "unaware" of the diagnosis of cancer and
who have a more hopeful outlook of the treatment [7]. A
study performed in Turkey, indicated that psychiatric
morbidity was significantly higher in patients who knew
that they had a cancer diagnosis. These findings suggest
that the awareness of cancer diagnosis is related to the
presence of psychiatric morbidity [8]. On the contrary,
some studies have shown that honest disclosure of the
truth does not worsen any dimension of quality of life in
general or emotional functioning in particular [9,10].
Since no studies has investigated the quality of life of Ira-
nian patients regarding knowledge of cancer diagnosis,
here we investigated about quality of life of Iranian cancer
patients; and compared it among those who knew their
diagnosis and those who did not. Because of high inci-
dence of esophageal and stomach cancer in Iran [11] it
was decided to select gastrointestinal cancer patients in an
attempt (i) to examine quality of life in these group of
cancer patients and (ii) to compare these variables among
those who knew their diagnosis and those who did not.
Methods
Design and data collection
An interview based prospective study was carried out to
measure quality of life in patients with gastrointestinal
cancer. Data were collected during November 2005 and
April 2006. The intention was to interview all gastrointes-
tinal cancer inpatients attending to a large teaching hospi-
tal (Imam Hospital) for their treatment in Tehran, Iran. To
assess patient's knowledge of the cancer diagnosis, both
patients and relatives were investigated separately. This
was achieved at the end of each interview. First we asked
relatives to indicate whether a patient knew his or her
diagnosis. Then to confirm this with patients, after a care-
ful consideration each patient was asked what was wrong
with he or she. Knowledge was assessed by patient's abil-
ity to acknowledge the illness and use the terms 'cancer' or
'tumor'. In Iran usually educated people use 'cancer' while
less well-educated individuals use 'tumor' when the diag-
nosis is a cancer related disease. Data on demographic
characteristics and clinical information including age,
gender, educational status, cancer site and time since diag-
nosis were extracted from case records. All participants in
the study were gastrointestinal cancer patients who were
diagnosed during one year ago. Patients who had cogni-
tive problems or were too sick to participate in the inter-
view were excluded.
Instruments
Quality of life was assessed using the European Organiza-
tion for Research and Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ-C30). This is a core cancer-
specific questionnaire containing 30 items on patient's
functioning, global quality of life, disease- and treatment
related symptoms [12]. It incorporates five functional
scales (physical, role, cognitive, emotional, and social),
three symptom scales (fatigue, pain and nausea and vom-
iting), and a global health and quality of life scale. The
remaining single items assess additional symptoms com-
monly reported by cancer patients (dyspnoea, appetite
loss, sleep disturbance, constipation, and diarrhea) and
also the perceived financial impact of the disease and
treatment. With the exception of two questions concern-
ing physical condition and global quality of life that were
rated on a 7-point scale, responses to all other questions
were on a 4-point scale (not at all, a little, quite a bit, very
much). The psychometric properties of the Iranian ver-
sion of the EORT QLQ-C30 are well documented. The
reliability coefficient for multi-item scales reported to
range from 0.48 to 0.98. Validity (performing known-
groups comparison analysis), also showed that all the
functional and symptom scales discriminated between
subgroups of patients differing in clinical status as defined
by their performance status and disease stage [13].
Statistical analysis
In accordance with procedures recommended by the
EORTC, score were linearly converted to a scale ranging
from 0 and 100 for each patient. For the functional and
global quality of life scales, higher scores represent a better
level of functioning. For the symptoms scales, higherBMC Cancer 2009, 9:39 http://www.biomedcentral.com/1471-2407/9/39
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scores represent worse conditions. The independent sam-
ples t-test was used for group comparisons. A P-value of
less than 0.05 was considered as statistically significant.
Then, if the differences between two groups were signifi-
cant analysis of variance was performed while knowledge
of diagnosis, educational status and cancer site considered
as fixed factors and age as covariate in order to see whether
the factors and covariate had any independent effects on
differences observed.
Ethics
Verbal consents obtained from all patients prior to inter-
view. With regard to cancer disclosure it is worth noting
that the information was being withheld from the patient
regardless of the present study. In Iran usually physicians
or relatives do not disclose cancer diagnosis to patients,
although at present there are some changes to the usual
practice. In addition, all patients get treatments they
needed or would have normally received. Patients were
asked to participate in the study to measure their health-
related quality of life while indicating we are using this
information for our research purposes. The study received
two approvals: one from Shahed University and one from
Cancer Institute, affiliated to Tehran University of Medical
Sciences.
Results
Patients' characteristics
In all 165 patients were approached during the recruit-
ment period. Of these 15 patients were excluded due to
exclusion criteria and 8 patients refused to participate in
the study due to dislike. Finally 142 patients were entered
into the study, giving 86% participation rate. The mean
age of patients was 54.1 (SD = 14.8) years, most patients
were married (86%), male (56%), illiterate (55%). Only
48% knew their cancer diagnosis whereas 52% did not
know. The diagnosis was as fallows: stomach (30%),
esophagus (29%), colon (22%), rectum (16%), and small
intestine (3%). The patients' demographic and clinical
characteristics are shown in Table 1.
Quality of life
Comparison of functioning and global quality of life
scores between those knew their diagnosis and those who
did not it was found that those who knew their diagnosis
showed a significant lower degree of physical (P = 0.001),
emotional (P = 0.014) and social functioning (P < 0.001).
Also the findings indicated that there were no statistically
significant differences between two groups in symptoms
scores, except for fatigue (P = 0.014) and financial difficul-
ties (P = 0.005). The results are shown in Table 2.
Since there were significant differences in age, educational
status and cancer site between two groups, further analysis
was carried out to examine whether these had any effects
on physical, emotional, and social functioning, fatigue
and financial difficulties. The results are shown in Table 3.
There were no clear patterns for effects of independent
variables studied on outcomes that are physical, emo-
tional and social functioning or fatigue and financial dif-
ficulties, but in all instances knowledge of diagnosis
showed significant effects on observed differences
between two groups.
Discussion
This was a study that compared quality of life in gastroin-
testinal cancer patients who knew their cancer diagnosis
and who did not. The most striking findings of the study
were the fact that patients who did not know their cancer
diagnosis showed better conditions on a number of qual-
ity of life subscales as measured by the EORTC QLQ-C-30.
The findings indicated that those who knew their diagno-
sis showed a significant lower degree of physical, social
and emotional functioning. A study of lung cancer
patients also showed comparable results [14]. Similarly in
Turkey and India it has been demonstrated that psychiat-
ric disorders occurred to lesser extent in patients who were
not aware of their cancer diagnosis. The authors con-
cluded that these patients had a more hopeful outlook to
the outcome of treatment [8,15]. However, studies from
different cultural backgrounds suggested that awareness
of cancer diagnosis and prognosis does not itself cause
emotional distress and honest disclosure of truth does not
worsen any dimension of quality of life [9,16,17].
In Iran the majority of physicians do not inform caner
patients about their true nature of illness, and most
patients who know their diagnosis obtain information
indirectly [18] and thus this might lead to a higher level of
emotional distress in patients who become aware of their
illness [19]. Studies from Greece also indicated that
although physicians have the tendency to tell the truth
more often today than in the past, the majorities still dis-
close the truth to the next of kin [20]. However, this
hypothesis warrants further validation.
There were no differences between symptoms scales
among patients who knew the cancer diagnosis and who
did not, except for fatigue that was higher in aware
patients. The high level of fatigue in this group could not
be due to age of patients, because the unaware patients
were younger. It is demonstrated that fatigue is more fre-
quent in elders [21], and in cancer patients age and fatigue
are not closely related [22]. One might argue since emo-
tional distress was higher in patients who knew the diag-
nosis thus they were more fatigued [23]. Our own
findings indicated that patients who scored higher on
emotional functioning were less fatigued while those who
scored lower on emotional functioning scored higher on
fatigue scale (Table 2).BMC Cancer 2009, 9:39 http://www.biomedcentral.com/1471-2407/9/39
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Table 1: Patients' demographic and clinical characteristics
All (n = 142) Did not know diagnosis (n = 74) Knew diagnosis (n = 68) P
No (%). No. (%) No. (%)
Age 0.001
Mean (SD) 54.1 (14.8) 58.2 (13.4) 50.2 (13.9)
Range 19–76 19–76 23–74
Gender 0.19
Male 79 (56) 45 (61) 34 (50)
Female 63 (44) 29 (39) 34 (50)
Marital status* 0.71
Single 13 (9) 6 (8.1) 7 (10.3)
Married 122 (86) 63 (85.1) 59 (86.8)
Widowed 7 95) 5 (6.8) 2 (2.9)
Educational status* 0.001
Illiterate 78 (55) 55 (74.3) 23 (33.8)
Primary 43 (30) 15 (20.3) 28 (41.2)
Secondary 12 (8.5) 3 (4.1) 9 (13.2)
College/university 9 (6.5) 1 (1.4) 8 (11.8)
Cancer site < 0.001
Esophagus 41 (29) 34 (45.9) 7 (10.3)
Stomach 42 (30) 20 (27) 22 (32.4
Small intestine 5 (3) 4 (5.4) 1 (1.5)
Colon 31 (22) 5 (6.8) 26 (38.2)
Rectum 23 (16) 11 (14.9) 12 (17.6)
Time since diagnosis
Mean (SD) 4.4 (3.2) 4.1 (3.2) 4.6 (3.0) 0.31
Range 1–12 1–12 1–12
* To carry out a valid test, the cells were merged.BMC Cancer 2009, 9:39 http://www.biomedcentral.com/1471-2407/9/39
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It is difficult to explain the superior physical functioning
in unaware patients. However, the finding might be
explained by the fact that the questions regarding physical
functioning (items 1 to five from the EORTC QLQ-C30)
were more global and most patients who knew their diag-
nosis indicated that they did not want to have a walk or
that they were too worried and preferred to stay at home.
For instance, when these patients were asked 'do you have
any problem in taking a long walk?'; thirty-seven out of 68
replied quite a bit and very much. Thus, the physical func-
tioning in this group was lower than comparison group.
There appear to be a strong relationship between illiteracy
and not knowing the diagnosis. The relevance of level of
education and knowledge of cancer diagnosis seems
worthwhile to be examined in the future studies. As we
suggested, with regard to cultural and resources of medical
services in the Middle East there should be two different
strategies for disclosure of cancer diagnosis: one for illiter-
ate or less educated people and one for people with higher
education [24]. However, evidence indicates that sensible
disclosure of diagnosis and prognosis is important and
satisfaction with information-giving is associated with a
better quality of life [25]. Unfortunately we did not study
this and to come to a sensible conclusion about knowl-
edge of cancer diagnosis and its effects on quality of life in
the future studies it is necessary that the attitudes of phy-
sicians about cancer disclosure also be examined. In other
Table 2: Patients' quality of life scores as measured by the EORTC QLQ-C30
Did not know diagnosis
(n = 74)
Knew diagnosis
(n = 68)
Mean (SD) Mean (SD) P
Functioning*
Physical functioning 84.7 (15.9) 74.7 (19.4) 0.001
Role functioning 67.3 (25.9) 69.8 (29.1) 0.58
Emotional functioning 69.4 (20.8) 60.2 (23) 0.014
Cognitive functioning 97.0 (10) 93.2 (16.3) 0.09
Social functioning 88.3 (16.2) 75.5 (24.2) < 0.0001
Global health, quality of life 65.0 (18.7) 59.5 (25.2) 0.14
Symptoms**
Insomnia 29.3 (32.6) 35.8 (36.1) 0.26
Fatigue 25.2 (19.3) 34.5 (24.8) 0.014
Pain 32.6 (27.3) 35.8 (31.8) 0.53
Dyspnoae 6.3 (14.2) 7.3 (20.6) 0.72
Constipation 13.5 (29.1) 21.4 (33.7) 0.14
Appetite loss 32.4 (32.5) 40.3 (36.9) 0.18
Diarrhoea 4.9 (15.3) 7.8 (16.4) 0.28
Nausea and vomiting 20.5 (29.4) 17.4 (25.8) 0.5
Financial difficulties 40.0 (37.8) 58.3 (38.4) 0.005
* The higher values indicated a higher level of functioning and quality of life, min.: 0, max.: 100
** The higher values indicate a greater degree of symptoms, min.: 0, max.: 100BMC Cancer 2009, 9:39 http://www.biomedcentral.com/1471-2407/9/39
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Table 3: The results obtained from analysis of variance while functioning and symptom scores considered as dependent variables and 
knowledge of cancer diagnosis, educational status and cancer site considered as fixed factors and age as a covariate.
Outcomes Covariate and fixed factors F statistics P
Physical functioning
Age 0.55 0.45
Educational status 1.23 0.29
Cancer site 2.14 0.07
Knowledge of diagnosis 6.73 0.01
Emotional functioning
Age 6.61 0.01
Educational status 2.31 0.08
Cancer site 1.51 0.20
Knowledge of diagnosis 5.05 0.02
Social functioning
Age 0.079 0.78
Educational status 3.01 0.03
Cancer site 2.57 0.04
Knowledge of diagnosis 4.71 0.03
Fatigue
Age 0.180 0.67
Educational status 0.698 0.55
Cancer site 2.45 0.05
Knowledge of diagnosis 4.67 0.03
Financial difficulties
Age 0.096 0.75
Educational status 0.918 0.43
Cancer site 1.28 0.25
Knowledge of diagnosis 5.45 < 0.0001BMC Cancer 2009, 9:39 http://www.biomedcentral.com/1471-2407/9/39
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words one might argue that it is not the knowledge of can-
cer diagnosis that affects quality of life and rather it is the
physicians' information-giving manner that contributes
to such findings.
With regard to disclosure of cancer diagnosis three initial
options could be assumed: physicians do not believe in
disclosing bad news to cancer patients; patients do not
want know their cancer diagnosis; and finally family car-
egivers do not allow physicians to disclose the diagnosis
to cancer patients. An interesting population-based study
from Sweden studying 907 widowers whose wives had
died of cancer revealed that although a large majority of
men prefer an immediate disclosure about the incurable
stage of their wife's illness, 41% of the husbands received
this information during the last week of the patient's life
or not at all [26]. As far as we know for instance in Iran it
is estimated that about 80% of physicians do not disclose
the cancer diagnosis to patients, although most patients
want to know the true diagnosis [18]. Similarly a study
from Taiwan showed that the arguments that cancer
patients from an Asian culture (that is Chinese/Taiwanese
culture) have different preferences regarding being
informed of their diagnosis and prognosis and that family
member have legitimate right in decision making could
not be supported by data obtained from terminally-ill
cancer patients [27]. As suggested in many traditional cul-
tures (e.g. most Asian countries or a few European cul-
tures) an effort to protect patient from despair and feeling
of hopelessness, family caregivers more often exclude
patients from the process of information exchange. Thus,
in such societies family plays an important role in the pro-
vision of care and information disclosure and they usually
decide on the patients' behalf [28]. However, the effect of
such protections on patients' quality of life is unclear. An
investigation from Taiwan, studying 1108 dyads of
patient-family caregivers showed that patient awareness
of prognosis, patient-family caregivers agreement on the
preferred place of death, and the subjective family caregiv-
ers burden had a significant effect on the quality of life of
terminally ill cancer patients [29].
This study showed that, unlike reports from western coun-
tries, there was a lower awareness of cancer diagnosis in
our study group. In general in most developing countries
physician-patient communication is poor. The other main
reason for not informing patients in Iran is that most peo-
ple, as in many middle-eastern countries, interpret the
diagnosis of cancer as equivalent to death and therefore
families may request physicians not to tell the patient the
truth [18].
Finally, one should be cautious that this study suffers
from some limitations. As suggested the argument that
cancer patients from an Asian culture have different pref-
erences about being informed of their diagnosis and prog-
nosis that dictate significantly modifying information
disclosure practices should be guided by direct investiga-
tion of attitudes regarding information disclosure from
cancer patients in Asian cultures and the impact of know-
ing diagnostic information on the outcomes (such as
QOL) of cancer patients [27,29]. Furthermore, at the time
of current project the Iranian version of the EORTC QLQ-
STO22, a site-specific measure of quality of life in patients
with gastric cancer was not available to use in this study.
Therefore it is important that in the future studies to sup-
plement the QLQ-C30 with the QLQ-STO22 [30] to have
a better understanding on the topic.
Conclusion
In conclusion, the study findings showed that patients
who did not know their cancer diagnosis had a better
physical, social and emotional quality of life. It seems that
due to cultural differences between countries cancer dis-
closure guidelines perhaps should be differing.
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